Navigation Links
Avanafil Data to be Presented at the Sexual Medicine Society of North America Meeting
Date:11/10/2011

MOUNTAIN VIEW, Calif., Nov. 10, 2011 /PRNewswire/ --

Highlights from Avanafil Development Program Include:

  • Early onset of action observed in placebo-controlled trials
  • Comparative in-vitro selectivity of avanafil, sildenafil, vardenafil and tadalafil
  • Safety and efficacy in post-prostatectomy population

  • VIVUS, Inc. (NASDAQ: VVUS) today announced that multiple abstracts will be presented at the Sexual Medicine Society of North America (SMSNA) on November 12, 2011 in Las Vegas, NV.  The SMSNA is the largest gathering of medical professionals specializing in sexual dysfunction and treatment in North America.

    The specific abstracts to be presented on November 12, 2011 include:

    A moderated poster presentation by Wayne Hellstrom, MD, Professor of Urology and Chief of Andrology (male infertility and sexual dysfunction) at Tulane University School of Medicine, entitled:

    Onset of Action and Time to Efficacy of Avanafil, a Novel, Rapid-Onset PDE5 Inhibitor in Men with Mild to Severe Erectile Dysfunction: Data From Phase 2 and Phase 3 Clinical TrialsDr. Hellstrom will report that in the largest, randomized, phase 3 study of avanafil (TA-301), 67% of the patients who attempted intercourse within 15 minutes of dosing were successful.  

    A moderated poster presentation by Run Wang, MD, Associate Professor of Surgery in the Division of Urology and holder of the Cecil M. Crigler, MD Chair in Urology at the University of Texas Health Science Center in Houston, entitled:

    Avanafil, a Highly Selective Phosphodiesterase Type 5 Inhibitor for the Treatment of Erectile Dysfunction: Selectivity for Eleven PDE Isozymes, in Comparison With Sildenafil, Tadalafil and VardenafilDr. Wang will share his in-vitro analysis of avanafil selectivity for eleven PDE isozymes, in compari
    '/>"/>

    SOURCE VIVUS, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Positive Results From Avanafil Phase 3 Study in Diabetics Presented at the 47th EASD Annual Meeting
    2. VIVUS Announces FDA Acceptance of Avanafil New Drug Application for Treatment of Erectile Dysfunction
    3. Positive Results From Avanafil Post-Prostatectomy Study Featured at Cancer Survivorship Meeting
    4. Positive Results from Long-Term Phase 3 Study of Avanafil Featured at American Urological Association Annual Meeting
    5. VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results
    6. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
    7. LX2931 Phase 2 Data to be Presented at the American College of Rheumatology Conference
    8. Discovery Labs Releases New AFECTAIR™ Performance Data Presented at the American Association for Respiratory Care Annual Meeting
    9. Caliper CEO Kevin Hrusovsky Presented Vision for Revolutionizing Medicine
    10. Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheims Two Investigational HCV Direct Acting Antivirals Presented at AASLD
    11. Bayer HealthCares MEDRAD Interventional Business Announces Five-Year Data of Cotavance® Drug Eluting Balloon with Paccocath® Technology to be Presented at 2011 TCT
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... -- ResMed (NYSE: RMD ) today announced its ... device manufacturer BMC Medical Co., Ltd. The ... below infringe ResMed,s patents, and entered an order prohibiting BMC ... the United States : , iVolve nasal ... nasal pillows mask , iVolve full face mask ...
    (Date:12/24/2014)... , Dec. 23, 2014   Assurex Health, ... support to healthcare providers for behavioral health and ... secured $30 million in equity financing from new ... Drosos , President and Chief Executive Officer. ... and development of Assurex Health,s GeneSight ® ...
    (Date:12/24/2014)... China , Dec. 23, 2014 ... pharmaceutical company that specializes in patented biopharmaceutical, modernized ... pharmaceutical ingredients (API) today announced that the Company ... its Good Manufacturing Practice (GMP) certificate of TPI,s ... Drug Administration,s (CFDA). The public notice period is ...
    Breaking Medicine Technology:ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3
    ... 2012 Pernix Therapeutics Holdings, Inc. (NYSE Amex: ... the introduction of Omeclamox-Pak® , a ten-day therapy ... mg) and amoxicillin capsules (500 mg) for the treatment ... infection and duodenal ulcer disease (active or one-year history) ...
    ... leading events organizer UBM Live announced strong ... event for buyers and sellers of high value chemistry. ... show which takes place from February 19th to 22nd ... Major pharmaceutical, fine and specialty chemical companies that have ...
    Cached Medicine Technology:Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in Gastroenterology Portfolio 2Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in Gastroenterology Portfolio 3Strong Booking Levels For Informex 2013 2Strong Booking Levels For Informex 2013 3
    (Date:12/26/2014)... 2014 Cooking and warming equipment ... of 5. This score reflects slightly positive negotiation conditions ... specialization, low switching costs and a low level of ... low availability of substitutes for cooking and warming equipment ... and aluminum, key inputs in the production process of ...
    (Date:12/26/2014)... (PRWEB) December 26, 2014 “Many people ... with personal injury claim issues and phone calls with ... released an article featuring their free eBook on ... helpful eBook on pedestrian and bicycle auto accident claims ... is fully capable of professionally handling their case while ...
    (Date:12/26/2014)... AZ (PRWEB) December 26, 2014 ... source for the best in heating, cooling and ... for 24 hour emergency services in 2014 with ... alike know that Arizona is known for its ... company that understands the intricacies and details of ...
    (Date:12/25/2014)... 26, 2014 The report “Nintedanib ... 2023” focuses on the current treatment landscape, unmet ... colorectal cancer market. Stivarga is a drug which ... rectal cancer. Boehringer Ingelheim is developing nintedanib (BIBF-1120), ... of refractory CRC in the US, Europe, and ...
    (Date:12/25/2014)... Recently, iFitDress.com, the popular online supplier of ... its new selection of black one-shoulder cocktail dresses . ... they are available at discounted prices, up to 70% off. ... last for three weeks only. You know, we have thousands ... interested in our new items can visit our website for ...
    Breaking Medicine News(10 mins):Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2
    ... , ... it,s time to shake off winter doldrums, lace up the running shoes and get moving. While ... System,s Geriatric Research, Education, and Clinical Center (GRECC) say that keeping active all year is the ... ...
    ... ... fertility in women and men, as well as infertility diagnosis, treatment and options. , ... (PRWEB) March 9, 2010 -- A ... are surprised when their attempts at conceiving aren,t successful within the first few months. , ...
    ... ... ... ... ...
    ... ... ... ... ...
    ... performing a hysterectomy is common practice to prevent the ... performed in 55 percent of all US women having ... article in the March/April issue of t Philadelphia, PA, ... oophorectomy) while performing a hysterectomy is common practice to ...
    ... , ... special pricing on cognitive skills testing in March, , ... Denver, CO (Vocus) March 9, 2010 -- Do you know the ... Month) and the local LearningRx cognitive skills’ experts are offering free tips, activities, ...
    Cached Medicine News:Health News:The VA Maryland Health Care System Offers Tips for Senior Citizens and Older Adults to Spring into Shape 2Health News:The VA Maryland Health Care System Offers Tips for Senior Citizens and Older Adults to Spring into Shape 3Health News:The VA Maryland Health Care System Offers Tips for Senior Citizens and Older Adults to Spring into Shape 4Health News:The VA Maryland Health Care System Offers Tips for Senior Citizens and Older Adults to Spring into Shape 5Health News:'Get Pregnant' Aims To Help Couples Conceive Naturally, Faster 2Health News:2010 Recipient of Minority Scholar Award Will Conduct Clinical Research on Leukemia 2Health News:2010 Recipient of Minority Scholar Award Will Conduct Clinical Research on Leukemia 3Health News:2010 Recipient of Minority Scholar Award Will Conduct Clinical Research on Leukemia 4Health News:2010 Recipient of Minority Scholar Award Will Conduct Clinical Research on Leukemia 5Health News:U.S. Senator Kit Bond Receives 2010 AOA Health Care Leadership Award 2Health News:U.S. Senator Kit Bond Receives 2010 AOA Health Care Leadership Award 3Health News:U.S. Senator Kit Bond Receives 2010 AOA Health Care Leadership Award 4Health News:U.S. Senator Kit Bond Receives 2010 AOA Health Care Leadership Award 5Health News:New study questions benefits of elective removal of ovaries during hysterectomy 2Health News:Free Brain IQ Quiz, Activities for Home “Brain-Boosting” and Seminar Offered from LearningRX Denver during National Brain Awareness Month 2Health News:Free Brain IQ Quiz, Activities for Home “Brain-Boosting” and Seminar Offered from LearningRX Denver during National Brain Awareness Month 3Health News:Free Brain IQ Quiz, Activities for Home “Brain-Boosting” and Seminar Offered from LearningRX Denver during National Brain Awareness Month 4
    ... creation of a vascular access, a correctly ... the utmost importance in many vascular procedures. ... seeking a high-precision tunneling instrument. The unique ... twisting or kinking for more accurate graft ...
    ... GORE-TEX Stretch Vascular Grafts have ... demanding vascular procedures. Recognized for exceptional ... the endorsement of renowned surgeons worldwide. ... dilatation and the spread of infection, ...
    ... vascular surgery, and the accompanying need for ... of graft be developed. Grafts must not ... also available in varying sizes and configurations ... has long been the prosthetic of choice ...
    ... newest vascular graft offering from W. L. ... surgical products for more than two decades, ... compression problems that can lead to ... of the benefits of a ring graft ...
    Medicine Products: